Compounds > h-d-phe-pip-arg-pna
Page last updated: 2024-09-03

h-d-phe-pip-arg-pna and rivaroxaban

h-d-phe-pip-arg-pna has been researched along with rivaroxaban in 1 studies

Compound Research Comparison

Studies
(h-d-phe-pip-arg-pna)		Trials
(h-d-phe-pip-arg-pna)		Recent Studies (post-2010)
(h-d-phe-pip-arg-pna)		Studies
(rivaroxaban)		Trials
(rivaroxaban)		Recent Studies (post-2010) (rivaroxaban)
95154,7415694,357

Protein Interaction Comparison

ProteinTaxonomyh-d-phe-pip-arg-pna (IC50)rivaroxaban (IC50)
Coagulation factor XHomo sapiens (human)0.0038

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Du, S; Harenberg, J; Krämer, R; Krämer, S; Wehling, M; Weiss, C1

Other Studies

1 other study(ies) available for h-d-phe-pip-arg-pna and rivaroxaban

ArticleYear
Measurement of Non-Vitamin K Antagonist Oral Anticoagulants in Patient Plasma Using Heptest-STAT Coagulation Method.
    Therapeutic drug monitoring, 2015, Volume: 37, Issue:3

    Topics: Administration, Oral; Anticoagulants; Antithrombins; Blood Coagulation; Dabigatran; Dipeptides; Enzyme Assays; Factor Xa Inhibitors; Pyrazoles; Pyridones; Rivaroxaban; Vitamin K; Whole Blood Coagulation Time

2015